Open original FDA record ↗Recall record
- FDA identifier
- Z-3134-2017
- Company in FDA record
- Biomerieux Inc
- FDA record creation date
- Sep 18, 2017
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Customer reports have indicated occurrences of atypical negative O129R reactions for Enterococcus casseliflavus ATCC(R) 700327(TM) in association with VITEK(R) 2 GP ID Lot 2420240403 and 2420303403, causing failure of the Quality Control (QC) testing for the VITEK(R) 2 GP ID card. The expected O129R reaction for ATCC 700327(TM) strain is positive.
Source facts
- Action
- bioMerieux sent an Urgent Product Removval Notice to all affected consignees (Subsidiaries) of bioMrieux, impacted by the identified issue, were notified of the FSCA and corrective action (FSCA notification) electronically on August 25, 2017. . The directions to the user are as follows: "Please implement the following actions at this time: We request you take the following action at this time: " Please confirm this letter has been distributed and reviewed by all appropriate personnel within your organization. " Please refrain from using the referenced test kits (VITEK 2 GP ID, Lots 2420240403 and 2420303403) in your laboratory. Destroy any of this product in your inventory, and contact your local bioMrieux representative for credit or replacement. " Please store this letter with your bioMrieux system documentation. " Complete the attached Acknowledgement Form and return it to your local bioMrieux representative." Consignees with questions were instructed to contact their local representative.
- Initiated
- 2017-08-25
- Root cause
- Under Investigation by firm
- Terminated
- 2020-11-09
- Distribution
- US and Angola, Argentina, Austria, Belarus, Belgium, Burkina Faso, Cameroon, Canada, China, Congo, Croatia, Egypt, France, Germany, Greece, Guam, Hungary, Israel, Italy, Latvia, Luxembourg, Macedonia, Mali, Mexico, Morocco, Netherlands, Nicaragua, Oman, Panama, Poland, Saudi Arabia, Serbia, South Africa, South Korea, Spain, Swaziland, Switzerland, Tunisia, Turkey, Turkmenistan, United Arab Emirates, United Kingdom
- Recall number
- Z-3134-2017
- Recall status
- Terminated
- CDRH record ID
- 158270
- FDA record created
- 2017-09-18
- Recall event number
- 77935